Patient-specific prostate segmentation in kilovoltage images for radiation therapy intrafraction monitoring via deep learning.
Authors
Affiliations (4)
Affiliations (4)
- Image X Institute, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia. [email protected].
- Image X Institute, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.
- Institute of Medical Physics, School of Physics, The University of Sydney, Sydney, NSW, Australia.
- Northern Sydney Cancer Centre, Royal North Shore Hospital, St Leonards, NSW, Australia.
Abstract
During radiation therapy, the natural movement of organs can lead to underdosing the cancer and overdosing the healthy tissue, compromising treatment efficacy. Real-time image-guided adaptive radiation therapy can track the tumour and account for the motion. Typically, fiducial markers are implanted as a surrogate for the tumour position due to the low radiographic contrast of soft tissues in kilovoltage (kV) images. A segmentation approach that does not require markers would eliminate the costs, delays, and risks associated with marker implantation. We trained patient-specific conditional Generative Adversarial Networks for prostate segmentation in kV images. The networks were trained using synthetic kV images generated from each patient's own imaging and planning data, which are available prior to the commencement of treatment. We validated the networks on two treatment fractions from 30 patients using multi-centre data from two clinical trials. Here, we present a large-scale proof-of-principle study of x-ray-based markerless prostate segmentation for globally available cancer therapy systems. Our results demonstrate the feasibility of a deep learning approach using kV images to track prostate motion across the entire treatment arc for 30 patients with prostate cancer. The mean absolute deviation is 1.4 and 1.6 mm in the anterior-posterior/lateral and superior-inferior directions, respectively. Markerless segmentation via deep learning may enable real-time image guidance on conventional cancer therapy systems without requiring implanted markers or additional hardware, thereby expanding access to real-time adaptive radiation therapy.